Physician profile
Tyler Hunter
NPI 1295303709
$3,666.31
in general payments reported to CMS, 2019-2025
12 companies · $3,637 in 2025
The $3,637 reported for 2025 was more than what 98% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $28.87 · 2025: $3,637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,423 · Food and Beverage: $1,243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,423.28 |
| Food and Beverage | $1,243.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,807.59 | 2025 | Intellis Adaptivestim, Inceptiv |
| Globus Medical, INC. | $849.40 | 2025 | Senza |
| Abbott Laboratories | $461.22 | 2025 | Proclaim |
| Abbvie INC. | $125.61 | 2025 | |
| Spr Therapeutics, INC | $123.97 | 2025 | Sprint Pns System |
| Biotronik Nro, INC. | $123.93 | 2025 | Prospera |
| Boston Scientific Corporation | $62.89 | 2025 | Intracept |
| Eagle Pharmaceuticals, INC. | $28.87 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.35 | 2025 | Livtencity |
| Veloxis Pharmaceuticals, INC. | $23.74 | 2025 | Envarsus |
| Merck Sharp & Dohme LLC | $19.90 | 2025 | Prevymis |
| Alexion Pharmaceuticals, INC. | $14.84 | 2025 | Ultomiris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Hunter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.